Your browser doesn't support javascript.
loading
Kinetics of anti-SARS-CoV-2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy.
Kastritis, Efstathios; Terpos, Evangelos; Evangelakou, Zoi; Theodorakakou, Foteini; Fotiou, Despina; Manola, Maria S; Gianniou, Despoina D; Bagratuni, Tina; Kanellias, Nikolaos; Migkou, Magdalini; Gavriatopoulou, Maria; Trougakos, Ioannis P; Dimopoulos, Meletios A.
Afiliación
  • Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Terpos E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Evangelakou Z; Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
  • Theodorakakou F; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Fotiou D; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Manola MS; Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
  • Gianniou DD; Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
  • Bagratuni T; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Kanellias N; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Migkou M; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Gavriatopoulou M; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Trougakos IP; Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
  • Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Am J Hematol ; 97(1): E27-E31, 2022 01 01.
Article en En | MEDLINE | ID: mdl-34778995
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas / SARS-CoV-2 / COVID-19 / Vacuna BNT162 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2022 Tipo del documento: Article País de afiliación: Grecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas / SARS-CoV-2 / COVID-19 / Vacuna BNT162 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2022 Tipo del documento: Article País de afiliación: Grecia